MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Interlaboratory cross-validation of CSF α-synuclein seeding aggregation assay for parkinsonisms

    J. Perez-Montesino, M. Fernandez, R. Ruiz-Garcia, L. Naranjo, C. Painous, A. Camara, A. Perez-Soriano, L. de Mena, Y. Compta (Barcelona, Spain)

    Objective: To evaluate CSF α-syn-SAA interlaboratory reproducibility in diagnosing Parkinson´s Disease (PD) and atypical parkinsonisms as well as interrogate the effect of changes in lot…
  • 2025 International Congress

    Clinical and Dopaminergic Characteristics of MSA-C Patients with Predominant Cerebellar Asymmetry

    DG. Park, YS. Kim, YS. An, JH. Yoon (Suwon, Republic of Korea)

    Objective: To identify multiple system atrophy–cerebellar type (MSA-C) patients with marked cerebellar asymmetry and compare their features with symmetrically affected patients. Background: While asymmetry is…
  • 2025 International Congress

    Alpha-Synuclein Promotes the Expression and Release of Neurofilament Light Chain from Oligodendrocytes in Multiple System Atrophy

    YC. Zheng, WY. Kou, GX. Yang, HH. Cai, C. Yang, SM. Li, BX. Zhu, JY. Wu, Y. Huang, ZW. Yu, T. Feng (Beijing, China)

    Objective: This study aims to determine the Neurofilament light chain (NfL) expression in oligodendrocytes, investigate whether excess α-synuclein (α-syn) impacts NfL expression, release, and functions…
  • 2025 International Congress

    Conjugal Parkinsonism

    CK. Tan (Singapore, Singapore)

    Objective: To report a case of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) in a couple. Background: Conjugal parkinsonism denotes an entity where…
  • 2025 International Congress

    Brain Target Engagement and Pharmacokinetic-Enzyme Occupancy (PK-EO) Relationship of FNP-223: A Novel Oral OGA Inhibitor for Progressive Supranuclear Palsy – Phase 1 PET Study

    R. Pokorny, J M. Ryan, E. Rabiner, G. Searle, C. Varona, M. Schneider, C. Wiessner, J F. Stallaert, B. Permanne, A. Quattropani, D. Beher (Lausanne, Switzerland)

    Objective: To determine the brain O-GlcNAcase (OGA) occupancy, following a single oral dose of FNP-223 (formerly ASN90) and to determine PK-EO relationship. Background: Preclinical evidence…
  • 2025 International Congress

    Exploring the Role of Aperiodic and Periodic Spectral Activity in Guiding Deep Brain Stimulation Electrode Selection for Childhood Dystonia

    T. Larsh, S. Vadivelu, J. Skoch, T. Lipps, D. Gilbert, S. Wu (Cincinnati, USA)

    Objective: To evaluate the potential of aperiodic and periodic neural activity in guiding clinical deep brain stimulation (DBS) programming for children with dystonia. Background: DBS…
  • 2025 International Congress

    Microstructural Changes in the Striatum Correlate With Clinical Symptoms in Wilson Disease

    A. Hausmann, S. Querbach, C. Rubbert, A. Schnitzler, J. Caspers, C. Hartmann (Düsseldorf, Germany)

    Objective: To evaluate microstructural changes in the dorsal striatum and their correlation with clinical symptoms in Wilson disease (WD). Background: Advanced diffusion models, including Neurite…
  • 2025 International Congress

    Development of Gene Panel by Next‐Generation Sequencing Approach for Diagnosis of Paroxysmal Movement Disorders

    PS. Somanna, RS. Sampath, PLK. Kukkle, AK. Kolandaswamy, VKN. Nanjundagowda, RP. P, UR. R, KK. Kotha, PA. Agarwal, SNS. N S, AR. Raina, PKS. Kumar S, GM. Majigoudra (Bangalore, India)

    Objective: To develop a targeted gene panel for Paroxysmal Movement Disorders using Whole Exome Sequencing. Background: Paroxysmal movement disorders (PMDs) are a neurological disorder, characterized…
  • 2025 International Congress

    The Impact of Non-Invasive Brain Stimulation Timing on Physiotherapy Outcomes for Parkinson’s Disease a Systematic Review with Dose-Response Analysis

    M. Guidetti, E. Ravizzotti, S. Giannoni-Luza, NV. Maiorana, S. Marceglia, T. Bocci, S. Oliveri, E. Pelosin, R. Pagani, AM. Previtera, A. Priori (Milan, Italy)

    Objective: To determine the best timing for non-invasive brain stimulation (NIBS) intervention to enhance physiotherapy-induced motor recovery in patients with Parkinson's disease (PwPD), and to…
  • 2025 International Congress

    Community Awareness of Parkinson’s Disease as a Driver of Stigma in Kilifi, Kenya

    N. Fothergill-Misbah, S. Unda, V. Nyadimo, M. Bitta (Newcastle upon Tyne, United Kingdom)

    Objective: To gain a holistic understanding of stigma surrounding Parkinson’s disease in Kenya from the perspective of those who are stigmatised, and those who might…
  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley